AKBA (Akebia Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on AKBA (Akebia Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

AKBA

Akebia Therapeutics, Inc.

clarify Drug Manufacturers - Specialty & Generic

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Implied Volatility Surging for Akebia Therapeutics Stock Options
Nov 13, 2025
Akebia Therapeutics (AKBA) Loses 39.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Nov 11, 2025
Akebia Therapeutics Inc (AKBA) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic ...
Nov 10, 2025
Vafseo® (vadadustat) Dialysis Dependent Patient Post Hoc Data Analysis: Composite of All-Cause Mortality and Hospitalization Outcomes Statistically More Favorable for Patients Receiving Vadadustat vs. ESAs
Nov 6, 2025
Akebia Therapeutics to Present at Upcoming Investor Conferences
Nov 4, 2025
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 3, 2025
Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights
Oct 30, 2025
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients
Oct 28, 2025
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics
Oct 15, 2025
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery
Oct 14, 2025
Is Intellia Therapeutics (NTLA) Outperforming Other Medical Stocks This Year?
Oct 8, 2025

Reviews